Zobrazeno 1 - 6
of 6
pro vyhledávání: '"e Silva, PMR"'
Autor:
Barreto, EO, Riederer, I, Arantes, ACS, Carvalho, VF, Farias-Filho, FA, Cordeiro, RSB, Martins, MA, Savino, W, e Silva, PMR
Publikováno v:
Memórias do Instituto Oswaldo Cruz, Volume: 100 Supplement 1, Pages: 127-130, Published: MAR 2005
We previously reported that alloxan-induced diabetes results in reduction in the number and reactivity of mast cells at different body sites. In this study, the influence of diabetes on thymic mast cells was investigated. Thymuses from diabetic rats
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______608::9b51c9330e561bad107df740a7af33f8
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762005000900022&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762005000900022&lng=en&tlng=en
Autor:
Ferreira TPT; Laboratory of Inflammation, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-360, Brazil., Guimarães FV; Laboratory of Inflammation, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-360, Brazil., Sá YAPJ; Laboratory of Inflammation, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-360, Brazil., da Silva Ribeiro NB; Laboratory of Inflammation, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-360, Brazil., de Arantes ACS; Laboratory of Inflammation, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-360, Brazil., de Frias Carvalho V; Laboratory of Inflammation, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-360, Brazil., Sousa LP; Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil., Perretti M; Department of Biochemical Pharmacology, The William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK., Martins MA; Laboratory of Inflammation, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-360, Brazil., E Silva PMR; Laboratory of Inflammation, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
Publikováno v:
Cells [Cells] 2022 Feb 22; Vol. 11 (5). Date of Electronic Publication: 2022 Feb 22.
Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients.
Autor:
Silva-Aguiar RP; Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Peruchetti DB; Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Rocco PRM; Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil.; Rio de Janeiro Innovation Network in Nanosystems for Health-NanoSAÚDE/Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Rio de Janeiro, Brazil., Schmaier AH; Case Western Reserve University, Cleveland, Ohio.; University Hospitals Cleveland Medical Center, Cleveland, Ohio., E Silva PMR; Rio de Janeiro Innovation Network in Nanosystems for Health-NanoSAÚDE/Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Rio de Janeiro, Brazil.; Laboratory of Inflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Martins MA; Rio de Janeiro Innovation Network in Nanosystems for Health-NanoSAÚDE/Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Rio de Janeiro, Brazil.; Laboratory of Inflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Carvalho VF; Rio de Janeiro Innovation Network in Nanosystems for Health-NanoSAÚDE/Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Rio de Janeiro, Brazil.; Laboratory of Inflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Pinheiro AAS; Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.; Rio de Janeiro Innovation Network in Nanosystems for Health-NanoSAÚDE/Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Rio de Janeiro, Brazil., Caruso-Neves C; Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil.; Rio de Janeiro Innovation Network in Nanosystems for Health-NanoSAÚDE/Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Rio de Janeiro, Brazil.
Publikováno v:
American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2020 Oct 01; Vol. 319 (4), pp. L596-L602. Date of Electronic Publication: 2020 Aug 12.
Autor:
Tavares LP; Immunopharmacology Laboratory, Department of Biochemistry and Immunology, Instituto de Ciências Biológicas, UFMG, Belo Horizonte, Brazil; Signaling in Inflammation Laboratory, Department of Clinical and Toxicological Analysis, Faculdade de Farmácia, UFMG, Belo Horizonte, Brazil; Pulmonary and Critical Care Medicine Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.. Electronic address: lupt26@gmail.com., Negreiros-Lima GL; Immunopharmacology Laboratory, Department of Biochemistry and Immunology, Instituto de Ciências Biológicas, UFMG, Belo Horizonte, Brazil; Signaling in Inflammation Laboratory, Department of Clinical and Toxicological Analysis, Faculdade de Farmácia, UFMG, Belo Horizonte, Brazil. Electronic address: grazieleleticia17@gmail.com., Lima KM; Immunopharmacology Laboratory, Department of Biochemistry and Immunology, Instituto de Ciências Biológicas, UFMG, Belo Horizonte, Brazil; Signaling in Inflammation Laboratory, Department of Clinical and Toxicological Analysis, Faculdade de Farmácia, UFMG, Belo Horizonte, Brazil; Post-Graduation Program in Pharmaceutical Sciences, Faculdade de Farmácia, UFMG, Belo Horizonte, Brazil. Electronic address: katiamaciellima@yahoo.com.br., E Silva PMR; Inflammation Laboratory, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil. Electronic address: patsilva1910@gmail.com., Pinho V; Immunopharmacology Laboratory, Department of Biochemistry and Immunology, Instituto de Ciências Biológicas, UFMG, Belo Horizonte, Brazil; Department of Morphology, Instituto de Ciências Biológicas, UFMG, Belo Horizonte, Brazil. Electronic address: vpinho@gmail.com., Teixeira MM; Immunopharmacology Laboratory, Department of Biochemistry and Immunology, Instituto de Ciências Biológicas, UFMG, Belo Horizonte, Brazil. Electronic address: mmtex.ufmg@gmail.com., Sousa LP; Immunopharmacology Laboratory, Department of Biochemistry and Immunology, Instituto de Ciências Biológicas, UFMG, Belo Horizonte, Brazil; Signaling in Inflammation Laboratory, Department of Clinical and Toxicological Analysis, Faculdade de Farmácia, UFMG, Belo Horizonte, Brazil; Post-Graduation Program in Pharmaceutical Sciences, Faculdade de Farmácia, UFMG, Belo Horizonte, Brazil. Electronic address: lipsousa72@gmail.com.
Publikováno v:
Pharmacological research [Pharmacol Res] 2020 Sep; Vol. 159, pp. 105030. Date of Electronic Publication: 2020 Jun 17.
Autor:
Santoro T; Laboratory of Inflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Azevedo CT; Laboratory of Inflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., E Silva PMR; Laboratory of Inflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Martins MA; Laboratory of Inflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Carvalho VF; Laboratory of Inflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Rio de Janeiro, Brazil.
Publikováno v:
Journal of leukocyte biology [J Leukoc Biol] 2019 Jan; Vol. 105 (1), pp. 131-142. Date of Electronic Publication: 2018 Sep 10.
Autor:
Coutinho DS; Laboratório de Inflamação, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Anjos-Valotta EA; Universidade Estadual da Zona Oeste, Rio de Janeiro, Brazil., do Nascimento CVMF; Laboratório de Inflamação, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Pires ALA; Laboratório de Inflamação, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Napimoga MH; Laboratory of Immunology and Molecular Biology, São Leopoldo Mandic Institute and Research Center, Campinas, Brazil., Carvalho VF; Laboratório de Inflamação, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Torres RC; Laboratório de Inflamação, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., E Silva PMR; Laboratório de Inflamação, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Martins MA; Laboratório de Inflamação, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Publikováno v:
Frontiers in immunology [Front Immunol] 2017 Jun 30; Vol. 8, pp. 740. Date of Electronic Publication: 2017 Jun 30 (Print Publication: 2017).